Discovery of novel morpholino–quinoxalines as PI3Kα inhibitors by pharmacophore-based screening-Reference-Cited by-同舟云学术

Discovery of novel morpholino–quinoxalines as PI3Kα inhibitors by pharmacophore-based screening

Published:2012 Issue:6 Volume:3 Page:659
ISSN:2040-2503
Container-title:MedChemComm
language:en
Short-container-title:Med. Chem. Commun.

Author:

Wu Peng,Su Yi,Liu Xiaowen,Yan Jingying,Ye Yong,Zhang Lei,Xu Jianchao,Weng Shaoyu,Li Yani,Liu Tao,Dong Xiaowu,Sun Maotang,Yang Bo,He Qiaojun,Hu Yongzhou

Publisher

Royal Society of Chemistry (RSC)

Subject

Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2012/MD/C2MD00255H

Reference13 articles.

1. Cancer-specific mutations in phosphatidylinositol 3-kinase

2. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

3. The emerging mechanisms of isoform-specific PI3K signalling

4. High Frequency of Mutations of the PIK3CA Gene in Human Cancers

5. PTEN loss in the continuum of common cancers, rare syndromes and mouse models

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thiourea Dioxide Catalyzed Sustainable Synthesis of Diverse Quinoxaline and Pyrazine Derivatives in Aqueous Medium at Ambient Temperature;ChemistrySelect;2024-06-03

2. Design of PI3K-mTOR Dual Inhibitors for Ovarian Cancer: Are We on the Right Track?;Current Medicinal Chemistry;2024-04-04

3. 3-Arylamino-quinoxaline-2-carboxamides inhibit the PI3K/Akt/mTOR signaling pathways to activate P53 and induce apoptosis;Bioorganic Chemistry;2021-09

4. Recent advances in the transition-metal-free synthesis of quinoxalines;RSC Advances;2021

5. 2,3-Dichloroquinoxaline as a versatile building block for heteroaromatic nucleophilic substitution: A review of the last decade;Arabian Journal of Chemistry;2020-01